Chemoinformaics analysis of 4a, 5,6,7,7a-hexahydrocyclopetan pyran-4,7-dicaroxylate
Molecular Weight | 150.221 | nRot | 1 |
Heavy Atom Molecular Weight | 136.109 | nRig | 11 |
Exact Molecular Weight | 150.104 | nRing | 2 |
Solubility: LogS | -2.451 | nHRing | 1 |
Solubility: LogP | 2.886 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 26.8371 |
nHD | 0 | BPOL | 15.7809 |
QED | 0.52 |
Synth | 4.555 |
Natural Product Likeliness | 2.176 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.041 |
HIA | 0.01 |
CACO-2 | -4.37 |
MDCK | 0.0000302 |
BBB | 0.475 |
PPB | 0.818972 |
VDSS | 1.446 |
FU | 0.167799 |
CYP1A2-inh | 0.452 |
CYP1A2-sub | 0.725 |
CYP2c19-inh | 0.111 |
CYP2c19-sub | 0.787 |
CYP2c9-inh | 0.028 |
CYP2c9-sub | 0.107 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.724 |
CYP3a4-inh | 0.451 |
CYP3a4-sub | 0.283 |
CL | 2.372 |
T12 | 0.476 |
hERG | 0.02 |
Ames | 0.091 |
ROA | 0.659 |
SkinSen | 0.571 |
Carcinogencity | 0.263 |
EI | 0.993 |
Respiratory | 0.178 |
NR-Aromatase | 0.013 |
Antiviral | No |
Prediction | 0.93719 |